Clinical Trials for Peptomyc

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Peptomyc

Clinical Trials (2)

NCT06650514
A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma
PHASE2Recruiting
10 participants
Started: Dec 27, 2024 · Completed: Dec 31, 2026
2 conditions9 sponsors1 location
NCT06059001
Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered Iv in Patients with PDAC
PHASE1Recruiting
30 participants
Started: Aug 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor6 locations